Corcept Therapeutics Revenue

Biotechnology Research • Redwood City, California, United States • 501-1000 Employees

Corcept Therapeutics revenue & valuation

Annual revenue	$716,100,000
Revenue per employee	$1,095,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,291,500,000
Total funding	$525,300

Key Contacts at Corcept Therapeutics

Stephen Smith

Senior Program Director, Oncology

John Mcfall

Associate Director, Talent Acquisition

Kimberly Bridges

Associate Director, Talent Acquisition

Chidi Nwosu

Associate Director, Fp&A

Hani Orangi

Director Human Resource Business Partner

Ji Chun

Director, Training & Operations

Danielle Cascerceri

Senior Director, Franchise Strategy

Bo Hyun

Regional Business Director

Priya Choudhry

Associate Director, Clinical Science

Michael Hershey

Senior Director, Trade, Gpo, And Key Accounts, Oncology Division.

Company overview

Headquarters	101 Redwood Shores Pkwy, Redwood City, California 94065, US
Phone number	+16503273270
Website	corcept.com
NAICS	541714
SIC	873
Founded	1998
Employees	501-1000
Socials

Corcept Therapeutics Email Formats

Corcept Therapeutics uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@corcept.com), used 53.8% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@corcept.com	53.8%
{first name}{last name}	johndoe@corcept.com	41.5%
{last name}{last name}	doedoe@corcept.com	3.8%

About Corcept Therapeutics

We’ve been unlocking the potential of cortisol modulation for more than 25 years. We’re leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators. In 2012, we received FDA approval of a groundbreaking cortisol receptor blocker and the first approved treatment for hypercortisolism (Cushing’s syndrome). Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation. What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.

Employees by Management Level

Total employees: 501-1000

Seniority

Employees

Entry

Director

Manager

Employees by Department

Corcept Therapeutics has 272 employees across 18 departments.

Departments

Number of employees

Funding Data

Explore Corcept Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2012-05-10	14	$525,300

Funding Insights

$525,300

Total funding amount

$525,300

Most recent funding amount

Number of funding rounds

Corcept Therapeutics Tech Stack

Discover the technologies and tools that power Corcept Therapeutics's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

reCAPTCHA

Security

Gravity Forms

Form builders

mOxie

JavaScript libraries

Underscore.js

JavaScript libraries

Swiper

JavaScript libraries

lit-element

JavaScript libraries

jQuery UI

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Frequently asked questions

Corcept Therapeutics is located in Redwood City, California, US.

You can reach Corcept Therapeutics at +16503273270.

Corcept Therapeutics generates an estimated annual revenue of $716,080,000. This revenue figure reflects the company's market position and business performance in its industry.

Corcept Therapeutics has an estimated valuation of $2,291,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Corcept Therapeutics was founded in 1998, making it 28 years old. The company has established itself as a significant player in its industry over this time.

Corcept Therapeutics has approximately 501-1000 employees. The company continues to grow its workforce to support its business operations and expansion.

Corcept Therapeutics has raised a total of $525,300 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Corcept Therapeutics

Stephen Smith

Senior Program Director, Oncology

John Mcfall

Associate Director, Talent Acquisition

Kimberly Bridges

Associate Director, Talent Acquisition

Chidi Nwosu

Associate Director, Fp&A

Hani Orangi

Director Human Resource Business Partner

Ji Chun